Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Roche Still Waiting For The Big Push
Seeking Alpha
Tue, 04/26/16 - 09:55 am
Tags:
Roche, ASCO, immuno-oncology, Amgen, Merck, Bristol-Myers Squibb
Amgen (AMGN): What to Expect from Q1 Earnings
Bidness, ETC
Sun, 04/24/16 - 12:02 pm
Tags:
Amgen, earnings
Can Humira Still Dominate In 2022?
Seeking Alpha
Thu, 04/21/16 - 03:28 pm
Tags:
Humira, Amgen, Bristol-Myers Squibb, Coherus Biosciences, Gilead Sciences, Intercept Pharma, JNJ, Novartis, Pfizer
New heart drugs struggle to win sales as doctors hold back
Yahoo/Reuters
Thu, 04/21/16 - 09:16 am
Tags:
Novartis, Entresto, Sanofi, Amgen, Praluent, Repatha, physicians
Why Biotech Will Benefit from Higher Drug Prices
Barron's
Wed, 04/20/16 - 06:41 pm
Tags:
biotech, drug pricing, JNJ, Gilead Sciences, Amgen, Biogen
Medivation: Biotech’s Most Wanted?
Barron's
Wed, 04/13/16 - 09:53 am
Tags:
Medivation, M&A, Amgen, Gilead Sciences, Sanofi, AstraZeneca
Biotech: If M&A is the Answer, What’s the Question?
Barron's
Tue, 04/12/16 - 03:42 pm
Tags:
biotech, M&A, Amgen, Biogen, Celgene, Gilead Sciences
New myeloma meds work better than the old, but they're far too expensive: Report
Fierce Biotech
Tue, 04/12/16 - 03:39 pm
Tags:
Multiple Myeloma, Bristol-Myers Squibb, Amgen, Takeda, Empliciti, Kyprolis, Ninlaro, Celgene, Revlimid
Big year at Amgen delivers $2M pay hike for CEO Bradway, to $16M
Fierce Pharma
Mon, 04/11/16 - 05:17 pm
Tags:
Amgen, Bob Bradway, Pharma CEOs, executive pay
Amgen balks over meeting to review cost of bone cancer drugs
Stat
Thu, 04/7/16 - 09:46 am
Tags:
Amgen, drug pricing, Kyprolis, Multiple Myeloma
Why Gilead Sciences and Amgen Can Eye Medivation As Acquisition Target
Bidness, ETC
Tue, 04/5/16 - 08:48 am
Tags:
Gilead Sciences, Amgen, Medivation, M&A
That blockbuster anti-NGF pain drug fulranumab? J&J doesn't want it anymore
Fierce Biotech
Fri, 04/1/16 - 10:10 am
Tags:
JNJ, fulranumab, anti-NGF, painkillers, Amgen
Will SCOTUS take up Sandoz' pivotal biosim case? New briefs call on court to weigh in
Fierce Pharma
Thu, 03/31/16 - 09:39 pm
Tags:
Supreme Court, Sandoz, Novartis, biosimilars, Amgen, Neupogen, Zarxio
Why Did Amgen Implement Multi-Pronged Strategy for Repatha?
Yahoo/Market Realist
Tue, 03/29/16 - 10:12 pm
Tags:
Amgen, Repatha
Amgen Asks the Supreme Court to Reject Challenge to Ruling that Notice of Commercial Marketing is Mandatory, But Asks for Review of Patent Dance Ruling Just in Case
FDA Law Blog
Tue, 03/29/16 - 11:12 am
Tags:
Amgen, patents, FDA, Zarxio, Neupogen
Biogen's Newer Problems; Their Relevance To The Biotech Sector
Seeking Alpha
Mon, 03/28/16 - 09:22 pm
Tags:
Biogen, Tecfidera, Merck, Ionis Pharmaceuticals, Gilead Sciences, Amgen, Regeneron
40% Of Amgen Sales Are Due To Fall Off The Patent Cliff
Seeking Alpha
Fri, 03/25/16 - 09:41 am
Tags:
Amgen, patents, patent cliff
Gilead, Biogen Troubles Remind Investors Why Strong Drug Patents Are Vital
TheStreet.com
Wed, 03/23/16 - 09:24 pm
Tags:
Gilead Sciences, Biogen, patents, Merck, Kyle Bass, Amgen, Regeneron, Sanofi
How Could Prolia Drive Amgen’s Valuations in 2016?
Yahoo/Market Realist
Wed, 03/23/16 - 04:08 pm
Tags:
Prolia, Amgen
Amgen's PCSK9 patent win 'reasonably likely' to push Sanofi's Praluent off the market: Analyst
Fierce Pharma
Tue, 03/22/16 - 04:12 pm
Tags:
Amgen, patents, Sanofi, PCSK9 inhibitors, Regeneron, Repatha, Praluent

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.